NSAIDs may diminish antibody and inflammatory responses to SARS-CoV-2 infection
New research caution against NSAID use when patients are infected with COVID-19.
New research finds anti-inflammatory agents might be beneficial for depression
The results were published in the Journal of Neurology, Neurosurgery & Psychiatry.